Publication Name	World Journal of Gastroenterology
Manuscript ID	100608
Country	China

Received	2024-08-21 06:50
Peer-Review Started	2024-08-26 08:44
To Make the First Decision
Return for Revision	2024-09-07 03:48
Revised	2024-09-20 01:33
Second Decision	2024-10-08 02:43
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-10-08 06:04
Articles in Press	2024-10-08 06:04
Publication Fee Transferred
Edit the Manuscript by Language Editor	2024-10-12 03:10
Typeset the Manuscript	2024-10-16 02:30
Publish the Manuscript Online	2024-10-31 10:39

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Substance Abuse
Manuscript Type	Letter to the Editor
Article Title	Helicobacter pylori, esophageal precancerous lesions, and proton pump inhibitor overuse
Manuscript Source	Invited Manuscript
All Author List	Feng Zhang, Hang Zhang, Yan-Miao Liu and Fu-Shan Tang
ORCID	Author(s) ORCID Number Feng Zhang http://orcid.org/0009-0000-5534-1978 Yan-Miao Liu http://orcid.org/0009-0004-4553-8127 Fu-Shan Tang http://orcid.org/0000-0001-8779-1041
Funding Agency and Grant Number
Corresponding Author	Fu-Shan Tang, PhD, Professor, Department of Clinical Pharmacy, Key Laboratory of Basic Pharmacology of Guizhou Province and School of Pharmacy, Zunyi Medical University, No. 6 Xuefu West Road, Xinpu New District, Zunyi 563006, Guizhou Province, China. fstang@vip.163.com
Key Words	Esophageal carcinoma; Helicobacter pylori; Esophageal precancerous lesions; Proton pump inhibitor; Drug abuse; Cancer
Core Tip	This article reviews a recent cohort study suggesting Helicobacter pylori (H. pylori) infection may protect against esophageal cancer. We discuss the controversial link between H. pylori and esophageal precancerous lesions and address risks associated with proton pump inhibitor (PPI) overuse. The implications for cancer treatment and the need for further research on PPI safety and efficacy in cancer patients are highlighted.
Publish Date	2024-10-31 10:39
Citation	<p>Zhang F, Zhang H, Liu YM, Tang FS. Helicobacter pylori, esophageal precancerous lesions, and proton pump inhibitor overuse. <i>World J Gastroenterol</i> 2024; 30(42): 4591-4596</p>
URL	https://www.wjgnet.com/1007-9327/full/v30/i42/4591.htm
DOI	https://dx.doi.org/10.3748/wjg.v30.i42.4591

Full Article (PDF)	WJG-30-4591-with-cover.pdf
Manuscript File	100608_Auto_Edited_072349.docx
Answering Reviewers	100608-answering-reviewers.pdf
Audio Core Tip	100608-audio.mp3
Conflict-of-Interest Disclosure Form	100608-conflict-of-interest-statement.pdf
Copyright License Agreement	100608-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	100608-non-native-speakers.pdf
Peer-review Report	100608-peer-reviews.pdf
Scientific Misconduct Check	100608-scientific-misconduct-check.png
Scientific Editor Work List	100608-scientific-editor-work-list.pdf
CrossCheck Report	100608-crosscheck-report.pdf